Quantitative analysis of chimerism after allogeneic stem cell transplantation by real-time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats, and Y-chromosome-specific sequences

American Journal of Hematology

Volumn 81, Issue 10, 2006, Pages 735-746

  Koldehoff, Michael ^a   Steckel, Nina K ^a   Hlinka, Michal ^a   Beelen, Dietrich W ^a   Elmaagacli, Ahmet H ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Chimerism; HSCT; Real time PCR; SNP PCR; Y chromosome PCR

Indexed keywords

ADOLESCENT; ADULT; AGAR GEL ELECTROPHORESIS; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHIMERA; DNA DETERMINATION; DONOR; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENE LOCUS; HEMATOLOGIC MALIGNANCY; HUMAN; INTERMETHOD COMPARISON; LEUKEMIA; LEUKEMIA RELAPSE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL; TANDEM REPEAT; Y CHROMOSOME;

ADOLESCENT; ADULT; AGED; CHROMOSOMES, HUMAN, Y; COHORT STUDIES; DNA; FEASIBILITY STUDIES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECURRENCE; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEX DETERMINATION (ANALYSIS); SEX-DETERMINING REGION Y PROTEIN; SURVIVAL RATE; TANDEM REPEAT SEQUENCES; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 33749580480     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20693     Document Type: Article

References (30)

1. Armitage JO. Bone marrow transplantation. N Engl J Med 1994;330:827-838.
2. Frankel W, Chan A, Corringham RE, Shepherd S, Rearden A, Wang-Rodriguez J. Detection of chimerism and early engraftment after allogeneic peripheral blood stem cell or bone marrow transplantation by short tandem repeats. Am J Hematol 1996;52:281-287.
3. Elmaagacli AH, Beelen DW, Becks HW, Mobascher A, Stockova J, Trzensky S, Opalka B, Schaefer UW. Molecular studies of chimerism and minimal residual disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation. Bone Marrow Transplant 1996;18:397-403.
4. Serrano J, Roman J, Sanchez J, Jimenez A, Castillejo JA, Herrera C, Gonzalez MG, Reina L, Rodriguez MC, Alvarez MA, Maldonado J, Torres A. Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210 (BCR-ABL) and p190 (BCR-ABL) after allogeneic bone marrow transplantation for chronic myeloid leukemia: increasing mixed myeloid chimerism and p190 (BCR-ABL) detection precede cytogenetic relaps. Blood 2000;95:2659-2685.
5. Formankova R, Honzatkova L, Moravcova J, Sieglova Z, Dvorakova R, Nadvomikova S, Vitek A, Lukasova M, Stary J, Brdicka R. Prediction and reversion of post-transplant relaps in patients with chronic myeloid leukaemia using mixed chimerism and residual disease detection and adoptive immunotherapy. Leuk Res 2000;24:339-347.
6. Shimoni A, Nagler A. Non-myeloablative stem cell transplantation (NST): chimerism testing as guidance for immune-therapeutic manipulations. Leukemia 2001;15:1967-1975.
7. Elmaagacli AH, Runkel K, Steckel N, Opalka B, Trenschel R, Seeber S, Scaefer UW, Beelen DW. A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase. Bone Marrow Transplant 2001;27:809-815.
8. Lawler M, Humphries P, McCann SR. Evaluation of mixed chimerism by in vitro amplification of dinucleotide repeat sequences using the polymerase chain reaction. Blood 1991;77:2504-2514.
9. Alizadeh M, Bernard M, Danic B, Dauriac C, Birebent B, Lapart C, Lamy T, Le Prise PY, Beauplet A, Bories D, Semana G, Quelvennec E. Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction. Blood 2002;99:4618-4625.
10. Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD. Marthe G, et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001;409:928-933.
11. Hochberg EP, Miklos DB, Neuberg D, Eichner DA, McLaughlin SF, Mattes-Ritz A, Alyea EP, Antin JH, Soiffer RJ, Ritz J. A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantation. Blood 2003;101:363-369.
12. Fredriksson M, Barbany G, Liljedahl U, Hermanson M, Kataja M, Syvänen AC. Assessing hematopoietic chimerism after allogeneic stem cell transplantation by multiplexed SNP genotyping using microarrays and quantitative anaylsis of SNP alleles. Leukemia 2004;18:255-266.
13. Durnam DM, Anders KR, Fisher L, O'Quigley J, Bryant EM, Thomas ED. Analysis of the origin of marrow cells in bone marrow transplant recipients using a Y-chromosome-specific in situ hydridization assay. Blood 1989;74:2220-2226.
14. Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, Wainscout JS, Johnson PJ, Chang AM, Hjelm NM. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62:768-775.
15. Fehse B, Chukhlovin A, Kuhlcke K, Marinetz O, Vorwig O, Renges H, Kruger W, Zabelina T, Dudina O, Finckenstein FG, Kroger N, Kabisch H, Hochhaus A, Zander AR. Real-time qunatitative Y chromosome-specific PCR (QYCS-PCR) for monitoring hematopoietic chimerism after sex-mismateched allogeneic stem cell transplantation. J Hematother Stem Cell Res 2001;10:419-425.
16. Olivier M, Chuang LM, Chang MS, Chen YT, Pei D, Ranade K, de Witte A, Allen J, Tran N, Curb D, Pratt R, Neefs H, de Arruda Indig M, Law S, Neri B, Wang L, Cox DR. High-throughput genotyping of single nucleotide polymorphisms using new biplex invader technology. Nucleic Acids Res 2002;30:e53.
17. Maas F, Schaap N, Kolen S, Zoetbrood A, Buno I, Dolstra H, de Witte T, Schattenberg A, van de Weil-van Kemenade E. Quantification of donor and reciepient hemopoietic cells by real-time PCR of single nucleotide polymorphisms. Leukemia 2003;17:621-629,
18. Thiede C, Bornhauser M, Ehninger G. Strategies and clinical implications of chimerism diagnostics after allogeneic hematopoietic stem cell transplantation. Acta Haematol 2004;112:16-23.
19. Mangioni S, Balduzzi A, Rivolta A, Rovelli A, Nesi F, Rossi V, Busca A, Uderzo C, Miniero R, Biondi A. Long-term persistence of hemopoietic chimerism following sex-mis-matched bone marrow transplantation. Bone Marrow Transplant 1997;20:969-973.
20. Buno I, Nava P, Simon A, Gonzalez-Rivera M, et al. A comparison of fluorescent in situ hybridization and multiplex short tandem repeat polymerase chain reaction for quantifying chimerism after stem cell transplantation. Haematologica 2005;90:1373-1379.
21. Bader P, Beck J, Frey A, Schlegel PG, Hebarth H, Handgretinger R, Einsele H, Niemeyer C, Benda N, Faul C, Kanz L, Niethammer D, Klingebiel T. Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relaps after allogeneic BMT. Bone Marrow Transplant 1998;21:487-495.
22. Bader P, Niethammer D, Willasch A, Kreyenberg H, Klingelbiel T. How and when should we monitor chimerism after allogeneic stem cell transplantation? Bone Marrow Transplant 2005;35:107-119.
23. Khan F, Agarwal A, Agrawal S. Significance of chimerism in hematopoietic stem cell transplantation: new variation on an old theme. Bone Marrow Transplant 2004;34:1-12.
24. Shastry BS. SNP alleles in human disease and evolution. J Hum Genet 2002;47:561-566.
25. Elmaagacli AH. Real-time PCR for monitoring minimal residual disease and chimerism in patients after allogeneic transplantation. Int J Hematol 2002;76Suppl 2:204-205.
26. Barrios M, Jimenez-Velasco A, Roman-Gomez J, Madrigal ME, Castillejo JA, Torres A, Heiniger A. Chimerism stauts is a useful preditor of relapse after allogeneic stem cell transplantation for acute leukemia. Heamtologica 2003;88:801-810.
27. Jimenez-Velasco A, Barrios M, Roman-Gomez J, Navarro G, Buno I, Castillejo JA, Rodriguez AI, Garcia-Gemar G, Torres A, Heiniger A. Reliable quantification of hematopoietic chimerism after allogeneic transplantation for acute leukemia using amplification by real-time PCR of null alleles and insertion/deletion polymorphisms. Leukemia 2005;19:336-343.
28. Naifeld V, Burnett W, Vlachos A, Scigliano E, Isola L, Fruchtman S. Interphase FISH analysis of sex-mismatched BMT utilizing dual color XY probes. Bone Marrow Transplant 1997;19:829-834.
29. Dewald GW, Schad CR, Christensen ER, Law ME, Zinsmeister AR, Stalboerger PG, Jalal SM, Ash RC, Jenkins RB. Fluorescence in situ hybridization with X and Y chromosome probes for cytogenetic studies on bone marrow cells after opposite sex transplantation. Bone Marrow Transplant 1993;12:149-154.
30. Thiede C, Kellermann T, Schwerdtfeger R, Baurmann H, Steudel C, Ehninger G, Bornhäuser M. Real-time PCR for the SRY-gene allows sensitive and quantitative chimerism analysis after allogeneic blood stem cell transplantation: clinical results in 43 patients. Bone Marrow Transplant 2003;31:S23-A181.